.png
)
Regulatory Update | CDSCO / DCC | July 2026 The Drugs Consultative Committee (DCC), at its 69th meeting, took up a proposal aimed at tightening control over one of the least regulated links in the pharmaceutical supply chain: the manufacturers…
High-Alcohol Oral Formulations Move Into Schedule H1: What G.S.R. 607(E) Means for Manufacturers The Drugs (Tenth Amendment) Rules, 2026 tighten the exemption net around alcohol-based oral medicines — and bring a familiar public health concern squarely into prescription-drug territory. Notification:…